Search results
Author(s):
Rachel M Drazner
,
Diana De Oliveira-Gomes
,
Jennifer T Thibodeau
,
et al
Added:
8 months ago
Author(s):
Diana Hui Ping Foo
Added:
11 months ago
ESC HF 25 - Findings from Heart2Miss suggest a hub-and-spoke model for early heart failure detection can detect patients with pre-HF and HF who were previously undiagnosed, can reduce tertiary center overload and improve novice performance.Dr Diana Foo (Sarawak General Hospital, Kuching, MY) discusses the findings from the Heart2Miss study, investigating a decentralised, community-based, rapid,…
View more
Author(s):
Phyo Htoo
Added:
1 year ago
EASD 24 - Dr Phyo Htoo (Harvard Medical School, Boston, MA, US) joins us to discuss a study investigating the comparative effectiveness of empagliflozin and glucagon-like peptide-1 receptor agonists in combination as compared to either medication alone in patients with type 2 diabetes.Interview Questions:1. What was the reasoning for this study?2. What was the patient population and study design…
View more
Author(s):
Nicolas M Van Mieghem
,
Azeem Latib
Added:
8 hours ago
ACC.26 late‑breaking trials, explained in one place.In this focused highlights series, Prof Nicolas Van Mieghem (Erasmus University, Rotterdam) and Dr Azeem Latib (Montefiore Medical Center, New York) break down the key interventional trials from ACC.26 and turn them into clear, practical takeaways for daily practice across Europe and the US.From HI‑PEITHO, STEMI‑DTU and CHIP‑BCIS3 to CHAMPION‑AF…
View more
Author(s):
Deepak L Bhatt
Added:
2 weeks ago
ACC 2026 — Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, US) delivers his expert verdict on three late-breaking clinical trials from ACC 2026 that are poised to influence cardiovascular care and future clinical guidelines.Dr Bhatt highlights data updates from the SURPASS-CVOT trial, exploring expanded cardiometabolic findings with tirzepatide versus dulaglutide, discusses the HI-PEITHO…
View more
Author(s):
Wayne Batchelor
,
Harriette Van Spall
Added:
2 weeks ago
ACC.26 – Late-breaker host Dr Harriette Van Spall (McMaster University, CA) is joined onsite by principal investigator Dr Wayne Batchelor (Inova Schar Heart and Vascular, US) to discuss the ALERT trial. ALERT is a pragmatic, multicentre, cluster-randomised study evaluating the Tempus Next platform, which continuously scans echocardiography reports to identify patients with severe aortic stenosis…
View more
Jan Sloves
Author
Author(s):
Anuradha Lala
Added:
2 weeks ago
ACC.26 - Dr Anuradha Lala-Trindade (Mount Sinai, New York, NY, US) provides her expert analysis of the most impactful late-breaking clinical trials presented at ACC.26, highlighting studies with the potential to influence clinical practice and shape future cardiovascular care. Key Late-Breaking Trials Discussed0:16 – STEMI-DTU: Primary Left Ventricular Unloading in Anterior ST-Segment Elevation…
View more
Brian C Fowler
Job title: Technical Director
Author
Amir Lerman
Research Area(s) / Expertise:
Author